1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceutical Analysis & Statistics 2020 - Brazil

Pharmaceutical Analysis & Statistics 2020 - Brazil

Customer Support

Talk to Ahmad

+1 718 618 4302

Publication dates

Publishers

  • All
    • Global Markets Direct

All regions

  • All
    • Latin America
      • Brazil

data types

1-3 of 3 reports

Glucosylceramidase - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 78 pages

Glucosylceramidase - Pipeline Review, H2 2019 Summary Glucosylceramidase (Acid Beta Glucosidase or Alglucerase or D Glucosyl N Acylsphingosine Glucohydrolase or Beta Glucocerebrosidase or Imiglucerase ...

  • Pharmaceutical
  • Psychotic Disorder
  • Therapy
  • Brazil
  • Product Initiative

Glucosylceramidase (Acid Beta Glucosidase or Alglucerase or D Glucosyl N Acylsphingosine Glucohydrolase or Beta Glucocerebrosidase or Imiglucerase or GBA or EC 3.2.1.45) - Pipeline Review, H2 2018

  • $ 3500
  • October 2018
  • 62 pages

Glucosylceramidase (Acid Beta Glucosidase or Alglucerase or D Glucosyl N Acylsphingosine Glucohydrolase or Beta Glucocerebrosidase or Imiglucerase or GBA or EC 3.2.1.45) - Pipeline Review, H2 2018 Su ...

  • Pharmaceutical
  • Psychotic Disorder
  • Therapy
  • Brazil
  • Protalix BioTherapeutics, Inc.

Glucosylceramidase (Acid Beta Glucosidase or Alglucerase or D Glucosyl N Acylsphingosine Glucohydrolase or Beta Glucocerebrosidase or Imiglucerase or GBA or EC 3.2.1.45) - Pipeline Review, H1 2018

  • $ 3500
  • April 2018
  • 60 pages

Glucosylceramidase (Acid Beta Glucosidase or Alglucerase or D Glucosyl N Acylsphingosine Glucohydrolase or Beta Glucocerebrosidase or Imiglucerase or GBA or EC 3.2.1.45) - Pipeline Review, H1 2018 Su ...

  • Pharmaceutical
  • Therapy
  • Brazil
  • Product Initiative
  • Protalix BioTherapeutics, Inc.



Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on